Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

79 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
In vitro susceptibility to posaconazole of 1,903 yeast isolates recovered in France from 2003 to 2006 and tested by the method of the European committee on antimicrobial susceptibility testing.
Lortholary O, Dannaoui E, Raoux D, Hoinard D, Datry A, Paugam A, Poirot JL, Lacroix C, Dromer F; YEASTS Group. Lortholary O, et al. Among authors: poirot jl. Antimicrob Agents Chemother. 2007 Sep;51(9):3378-80. doi: 10.1128/AAC.00496-07. Epub 2007 Jun 18. Antimicrob Agents Chemother. 2007. PMID: 17576839 Free PMC article.
Prior caspofungin exposure in patients with hematological malignancies is a risk factor for subsequent fungemia due to decreased susceptibility in Candida spp.: a case-control study in Paris, France.
Blanchard E, Lortholary O, Boukris-Sitbon K, Desnos-Ollivier M, Dromer F, Guillemot D; French Mycosis Study Group. Blanchard E, et al. Antimicrob Agents Chemother. 2011 Nov;55(11):5358-61. doi: 10.1128/AAC.00690-11. Epub 2011 Aug 22. Antimicrob Agents Chemother. 2011. PMID: 21859944 Free PMC article.
Comparative in vitro activities of caspofungin and micafungin, determined using the method of the European Committee on Antimicrobial Susceptibility Testing, against yeast isolates obtained in France in 2005-2006.
Dannaoui E, Lortholary O, Raoux D, Bougnoux ME, Galeazzi G, Lawrence C, Moissenet D, Poilane I, Hoinard D, Dromer F; YEASTS Group. Dannaoui E, et al. Antimicrob Agents Chemother. 2008 Feb;52(2):778-81. doi: 10.1128/AAC.01140-07. Epub 2007 Dec 10. Antimicrob Agents Chemother. 2008. PMID: 18070978 Free PMC article.
International retrospective analysis of 73 cases of invasive fusariosis treated with voriconazole.
Lortholary O, Obenga G, Biswas P, Caillot D, Chachaty E, Bienvenu AL, Cornet M, Greene J, Herbrecht R, Lacroix C, Grenouillet F, Raad I, Sitbon K, Troke P; French Mycoses Study Group. Lortholary O, et al. Antimicrob Agents Chemother. 2010 Oct;54(10):4446-50. doi: 10.1128/AAC.00286-10. Epub 2010 Jul 12. Antimicrob Agents Chemother. 2010. PMID: 20625156 Free PMC article.
Candida spp. with acquired echinocandin resistance, France, 2004-2010.
Dannaoui E, Desnos-Ollivier M, Garcia-Hermoso D, Grenouillet F, Cassaing S, Baixench MT, Bretagne S, Dromer F, Lortholary O; French Mycoses Study Group. Dannaoui E, et al. Emerg Infect Dis. 2012 Jan;18(1):86-90. doi: 10.3201/eid1801.110556. Emerg Infect Dis. 2012. PMID: 22257484 Free PMC article.
79 results